Here is a complete, textbook-sourced overview of gout.
Gout
Definition
Gout is a metabolic and inflammatory disease marked by transient attacks of acute arthritis initiated by deposition of monosodium urate (MSU) crystals in and around joints, resulting from sustained hyperuricemia (serum uric acid > 6.8 mg/dL - the limit of urate solubility in serum).
"Gout is a disease of both metabolism and inflammation, and its pathogenesis requires the intersection of two distinct processes: (1) the intrinsic accumulation of urate, at levels sufficient to drive the precipitation of MSU crystals, and (2) an inflammatory response to the crystals so formed."
- Firestein & Kelley's Textbook of Rheumatology
Biochemical Basis - Connection to Purine Metabolism
Uric acid is the end product of purine catabolism in humans. Purines (adenine, guanine) from DNA/RNA breakdown and dietary sources are ultimately degraded to uric acid via xanthine oxidase (XO).
Key steps:
- Purines → Hypoxanthine → Xanthine → Uric acid (via Xanthine oxidase)
- Humans lack uricase (present in most mammals), so uric acid is the terminal product rather than the more soluble allantoin
Classification of Gout
| Type | Mechanism | Examples |
|---|
| Primary gout (90%) | Reduced uric acid excretion (unknown cause) | Polymorphisms in URAT1, GLUT9, KCNQ1 transporters |
| Primary - enzyme defect | Overproduction | Partial HGPRT deficiency, PRPP synthetase superactivity |
| Secondary - overproduction | High cell turnover → excess purines | Leukemia, chemotherapy, Lesch-Nyhan syndrome |
| Secondary - underexcretion | Reduced renal clearance | Chronic kidney disease, thiazide diuretics, lead poisoning |
"In >90% of individuals with hyperuricemia, the cause is underexcretion of uric acid."
- Lippincott Biochemistry, 8th ed.
Risk factors:
- Male sex (90% of cases)
- Age (usually develops after 20-30 years of hyperuricemia)
- Alcohol consumption
- Obesity
- Diet rich in meat, seafood (shellfish), fructose
- Drugs: thiazide diuretics, low-dose aspirin, cyclosporine
- Genetic predisposition
Pathogenesis - The Inflammatory Cascade
The sequence of events (Robbins & Kumar Pathologic Basis of Disease):
- Hyperuricemia → MSU crystals precipitate in the joint space (cooler peripheral joints favor crystal formation)
- Resident synovial macrophages phagocytose MSU crystals
- Crystals activate the NLRP3 inflammasome → caspase-1 activation → release of IL-1β (the master cytokine)
- IL-1β triggers massive neutrophil recruitment into the joint
- Neutrophils phagocytose crystals → phagolysosomes rupture → release of proteases, free radicals, arachidonic acid metabolites
- Vicious cycle: inflammation → more neutrophils → more crystal phagocytosis → more tissue damage
- Acute attack typically remits in days to weeks as crystals are solubilized
Clinical Stages
| Stage | Features |
|---|
| Asymptomatic hyperuricemia | Elevated urate, no symptoms. Only ~10% ever develop gout |
| Acute gouty arthritis | Sudden severe joint pain, redness, warmth, swelling. Classic: 1st metatarsophalangeal joint (podagra). Starts at night, peaks in 24 hrs |
| Intercritical gout | Symptom-free intervals between attacks |
| Chronic tophaceous gout | Persistent inflammation, tophi deposits, joint destruction |
Morphology / Pathology
Acute phase: Dense neutrophilic infiltrate in synovium and synovial fluid. Slender needle-shaped urate crystals inside neutrophils.
Chronic tophaceous arthritis: Tophi - nodular aggregates of MSU crystals + inflammatory tissue in synovium and periarticular tissue → severe cartilage damage.
Clinical photo showing a tophus on the finger (monosodium urate crystal deposit):
Diagnosis
The gold standard is synovial fluid aspiration with polarized light microscopy:
"Demonstration of uric acid crystals in joint aspirate fluid is pathognomonic for gout."
- Tietz Textbook of Laboratory Medicine, 7th ed.
Key microscopy finding: Needle-shaped MSU crystals showing negative birefringence under compensated polarized light - crystals appear yellow when parallel to the polarizer axis.
Important: Serum uric acid is often normal during an acute attack and is NOT a component of the diagnostic criteria alone.
Treatment
Acute Attack
| Drug | Mechanism | Notes |
|---|
| Colchicine | Inhibits microtubule formation → limits neutrophil migration into joint | No effect on uric acid levels |
| NSAIDs (e.g., indomethacin) | Inhibit prostaglandin synthesis → reduce inflammation | First choice if no contraindications |
| Corticosteroids (e.g., prednisone) | Broad anti-inflammatory | Used when NSAIDs/colchicine contraindicated |
Long-Term Urate-Lowering Therapy (ULT)
Target: serum uric acid < 6.5 mg/dL (below saturation point)
| Drug | Mechanism | Use in |
|---|
| Allopurinol | Structural analog of hypoxanthine; inhibits xanthine oxidase (XO) → reduces uric acid synthesis | Overproducers; most common first-line ULT |
| Febuxostat | Non-purine XO inhibitor | Allopurinol-intolerant patients |
| Probenecid / Sulfinpyrazone | Uricosuric - increase renal excretion of uric acid | Underexcretors with normal renal function |
Allopurinol is oxidized to oxypurinol, a long-lived inhibitor of XO. This causes accumulation of hypoxanthine and xanthine - both more soluble than uric acid and less likely to form crystals.
- Lippincott Biochemistry, 8th ed.
Complications
- Urate nephropathy - MSU crystal deposition in renal interstitium → chronic kidney disease
- Uric acid urolithiasis - kidney stones (radiolucent on X-ray)
- Joint destruction - from chronic tophaceous arthritis
- Cardiovascular disease - hyperuricemia is an independent risk factor
Diet and Lifestyle
Foods that increase uric acid: red meat, organ meats, shellfish, beer, fructose-sweetened drinks, alcohol.
Foods that decrease risk: low-fat dairy products, cherries, vitamin C, adequate hydration.
The
2024 Chinese Guidelines for Hyperuricemia and Gout (PMID 40692263) reinforce that dietary modification combined with pharmacological ULT is the standard of care, with special attention to comorbidities like CKD and cardiovascular disease.